University of Paris 5 - René Descartes / Université Paris V René Descartes

Placenta Imaging Workshop 2018 report: Multiscale and multimodal approaches (2019) Slator P, Aughwane R, Cade G, Taylor D, David AL, Lewis R, Jauniaux E, et al. Journal article, Review article Three-generation households and child mental health in European countries (2019) Masfety VK, Aarnink C, Otten R, Bitfoi A, Mihova Z, Lesinskiene S, Carta MG, et al. Journal article GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE (2019) Wong L, Mescia F, Alberici F, Ball MJ, Baslund B, Brenchley P, Bruchfeld A, et al. Conference contribution The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of experts (2019) Spada M, Baron R, Elliott PM, Falissard B, Hilz MJ, Monserrat L, Tondel C, et al. Journal article, Review article Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy (2019) Wanner C, Gerrnain DP, Hilz MJ, Spada M, Falissard B, Elliott PM Journal article, Editorial Ectodermal dysplasias: Classification and organization by phenotype, genotype and molecular pathway (2019) Wright JT, Fete M, Schneider H, Zinser M, Koster MI, Clarke AJ, Hadj-Rabia S, et al. Journal article The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts. (2019) Germain DP, Arad M, Burlina A, Elliott PM, Falissard B, Feldt-Rasmussen U, Hilz MJ, et al. Journal article The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts. (2019) Germain DP, Elliott PM, Falissard B, Fomin VV, Hilz MJ, Jovanovic A, Kantola I, et al. Journal article, Review article Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology (2019) Butler EA, Baron M, Fogo AB, Frech T, Ghossein C, Hachulla E, Hoa S, et al. Journal article Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual (2019) Fasano S, Riccardi A, Messiniti V, Caramaschi P, Rosato E, Maurer B, Smith V, et al. Journal article